| Lamoure Drug Store | |
| 100 1st Ave Sw, Ste 8, Lamoure, North Dakota 58458 | |
| (701) 883-5339 |
| Name | Lamoure Drug Store |
|---|---|
| Organization Name | Lamoure Drug Store, Inc. |
| Location | 100 1st Ave Sw, Ste 8, Lamoure, North Dakota 58458 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (701) 883-5339 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Norgine B.V. and Innovacell today announced they have entered into an exclusive licensing agreement for Europe, SADAC and MENA for ICEF15. Innovacell and Norgine will co-develop ICEF15 and Norgine will commercialise the product. The start of the ICEF15 phase IIb clinical trial is imminent and it is anticipated that the first patient will be dosed in Q1 2014.
A National Institutes of Health-funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid overdose is associated with significant reductions in opioid related mortality.
Amgen announced today the publication of results from a Phase 3 trial (the '147 study) that evaluated XGEVA (denosumab) for use in preventing or delaying the onset of bone metastases in men with nonmetastatic castration-resistant prostate cancer.
Researchers from the Max Planck Institute for Human Development in Berlin have shown that synchronization emerges between brains when making music together, and even when musicians play different voices. In a study published November 29th in Frontiers in Neuroscience, Johanna S-nger and her team used electrodes to record the brain waves of guitarists while they played different voices of the same duet.
Biomet, Inc. today announced that it has priced its previously announced offering of $550 million aggregate senior notes due 2020, which has been increased to $1.0 billion aggregate principal amount of senior notes due 2020, at an issue price of 6.500%.
› Verified 3 days ago
| NPI Number | 1740249929 |
| Organization Name | LAMOURE DRUG STORE, INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 100 1st Ave Sw, Lamoure, ND 58458 |
| Phone Number | 701-883-5339 |
News Archive
Norgine B.V. and Innovacell today announced they have entered into an exclusive licensing agreement for Europe, SADAC and MENA for ICEF15. Innovacell and Norgine will co-develop ICEF15 and Norgine will commercialise the product. The start of the ICEF15 phase IIb clinical trial is imminent and it is anticipated that the first patient will be dosed in Q1 2014.
A National Institutes of Health-funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid overdose is associated with significant reductions in opioid related mortality.
Amgen announced today the publication of results from a Phase 3 trial (the '147 study) that evaluated XGEVA (denosumab) for use in preventing or delaying the onset of bone metastases in men with nonmetastatic castration-resistant prostate cancer.
Researchers from the Max Planck Institute for Human Development in Berlin have shown that synchronization emerges between brains when making music together, and even when musicians play different voices. In a study published November 29th in Frontiers in Neuroscience, Johanna S-nger and her team used electrodes to record the brain waves of guitarists while they played different voices of the same duet.
Biomet, Inc. today announced that it has priced its previously announced offering of $550 million aggregate senior notes due 2020, which has been increased to $1.0 billion aggregate principal amount of senior notes due 2020, at an issue price of 6.500%.
› Verified 3 days ago
News Archive
Norgine B.V. and Innovacell today announced they have entered into an exclusive licensing agreement for Europe, SADAC and MENA for ICEF15. Innovacell and Norgine will co-develop ICEF15 and Norgine will commercialise the product. The start of the ICEF15 phase IIb clinical trial is imminent and it is anticipated that the first patient will be dosed in Q1 2014.
A National Institutes of Health-funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid overdose is associated with significant reductions in opioid related mortality.
Amgen announced today the publication of results from a Phase 3 trial (the '147 study) that evaluated XGEVA (denosumab) for use in preventing or delaying the onset of bone metastases in men with nonmetastatic castration-resistant prostate cancer.
Researchers from the Max Planck Institute for Human Development in Berlin have shown that synchronization emerges between brains when making music together, and even when musicians play different voices. In a study published November 29th in Frontiers in Neuroscience, Johanna S-nger and her team used electrodes to record the brain waves of guitarists while they played different voices of the same duet.
Biomet, Inc. today announced that it has priced its previously announced offering of $550 million aggregate senior notes due 2020, which has been increased to $1.0 billion aggregate principal amount of senior notes due 2020, at an issue price of 6.500%.
› Verified 3 days ago
Lamoure Drug Store Type: Durable Medical Equipment & Medical Supplies Supplier Location: 100 1st Ave Sw, Lamoure, North Dakota 58458 Phone: (701) 883-5339 |